Could a vaccine stop Alzheimer's before it starts?
⭐️ VACCINE ⭐️
Not yet recruiting
This early-stage study tests a new vaccine called DUVAX in 24 healthy adults aged 40-65. The vaccine aims to train the immune system to attack two proteins linked to Alzheimer's disease. The main goal is to check safety and see if the vaccine produces a protective immune response…
Phase: PHASE1 • Sponsor: Nuravax, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:55 UTC